Wenjiao Tang

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0001-5576-1788

发表论文 43 篇 · 总被引 170 次 · h-index 7

代表论文

• A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria (2023 · The Lancet Regional Health - Western Pacific · 被引 40)
• Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China (2023 · Frontiers in Pharmacology · 被引 9)
• Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review (2024 · Frontiers in Oncology · 被引 8)
• Angioimmunoblastic T‐cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell‐free DNA profiling (2023 · British Journal of Haematology · 被引 8)
• Performance of Large Language Models in Diagnosing Rare Hematologic Diseases and the Impact of Their Diagnostic Outputs on Physicians: Combined Retrospective and Prospective Study (2025 · Journal of Medical Internet Research · 被引 7)
• Noncoding RNAs in the crosstalk between multiple myeloma cells and bone marrow microenvironment (2023 · Cancer Letters · 被引 7)